Nextcure to present at 24th annual needham virtual healthcare conference

Beltsville, md., april 04, 2025 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will present at the 24th annual needham virtual healthcare conference on thursday, april 10th, at 8:45 am et.

NXTC Ratings Summary

NXTC Quant Ranking